A randomized, double-blind, multicenter comparison of gatifloxacin versus ciprofloxacin in the treatment of complicated urinary tract infection and pyelonephritis

Clinical Therapeutics

Volumn 24, Issue 2, 2002, Pages 223-236

  Cox, Clair E ^a   Marbury, Thomas C ^b   Pittman, Walter G ^c   Brown, Gary L ^d   Auerbach, Stephen M ^e   Fox, Barry C ^f   Yang, Joanna Y ^g  

^a UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

^b ORLANDO CLINICAL RESEARCH CENTER   (United States)

^c Lloyd Nolan Urology Center   (United States)

^d PharmaTex Research   (United States)

^e California Professional Research   (United States)

^f Dean Clinic   (United States)

^g BRISTOL MYERS SQUIBB   (United States)

Author keywords

Ciprofloxacin; Complicated urinary tract infection; Gatifloxacin; Pyelonephritis; Quinolones; Treatment

Indexed keywords

CIPROFLOXACIN; GATIFLOXACIN;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIARRHEA; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG TOLERABILITY; ESCHERICHIA COLI; FEMALE; GRAM NEGATIVE BACTERIUM; GRAM POSITIVE BACTERIUM; HUMAN; KLEBSIELLA PNEUMONIAE; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; NAUSEA; PYELONEPHRITIS; RANDOMIZED CONTROLLED TRIAL; URINARY TRACT INFECTION; VERTIGO; VOMITING;

EID: 0036194340     PISSN: 01492918     EISSN: 1879114X     Source Type: Journal    
DOI: 10.1016/S0149-2918(02)85019-6     Document Type: Article

References (19)

1. A practical guide to the management of complicated urinary tract infection
2. Management of bacterial urinary tract infections in adults
3. Evaluation of new anti-infective drugs for the treatment of urinary tract infection
4. Urinary tract infections in females
5. Selected aspects of the socioeconomic impact of nosocomial infections: Morbidity, mortality, cost, and prevention
6. Mortality associated with nosocomial urinary-tract infection
7. Urinary tract infections in the elderly
8. Complicated urinary tract infections
9. Levofloxacin versus ciprofloxacin versus lomefloxacin in acute pyelonephritis
10. Comparison of the antibacterial activities of the quinolones Bay 12-8039, gatifloxacin (AM 1155), trovafloxacin, clinafloxacin, levofloxacin and ciprofloxacin
11. In vitro activity of gatifloxacin compared with gemifloxacin, moxifloxacin, trovafloxacin, ciprofloxacin, and ofloxacin against uropathogens cultured from patients with complicated urinary tract infections
12. Epidemiology and frequency of resistance among pathogens causing urinary tract infections in 1,510 hospitalized patients: A report from the SENTRY Antimicrobial Surveillance. Program (North America)
13. Use of ciprofloxacin versus use of aminoglycosides for therapy of complicated urinary tract infections: Prospective, randomized clinical and pharmacokinetic study
14. DNA topoisomerase targets of the fluoroquinolones: A strategy for avoiding bacterial resistance
15. Worldwide prevalence of antimicrobial resistance in Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis in the SENTRY Antimicrobial Surveillance Program, 1997-1999
16. Complicated urinary tract infections